Scientists have developed a new iron-based catalyst that improves the typically low hydrogen atom economy (HAE) in the direct ...

Discover key Q3 2025 earnings insights for Arcturus Therapeutics: pipeline progress, regulatory updates, and financial outlook.

Discover ProFrac's Q3 2025 earnings highlights—cost-saving strategies, dedicated fleet focus, and future outlook amid sector volatility.

Back in September, OpenAI announced GPT-5-Codex, a new GPT-5 model that is optimized for agentic coding in Codex. Since GPT-5 ...

Leading AI firms claim to prioritize social welfare. How should firms with a social mandate price and deploy AI? We derive pricing formulas that depart from profit maximization by incorporating ...

We're here to help you win more at fantasy football — and have fun doing it. Award-winning analyst Scott Pianowski will deliver actionable advice to entertain, inform and assist in drafting, lineup ...

Enterprises are racing to deploy AI tools, but few can prove whether those tools actually work. New York - based Parable ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...